We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

87 hedge funds and large institutions have $230M invested in Abeona Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $2.29M | Put options by funds: $732K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.11% less ownership

Funds ownership: 2.72% → 2.61% (-0.11%)

1% less capital invested

Capital invested by funds: $232M → $230M (-$2.3M)

12% less funds holding

Funds holding: 99 → 87 (-12)

26% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 31

75% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 16

Holders
87
Holders Change
-12
Holders Change %
-12.12%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
23
Reduced
31
Closed
16
Calls
$2.29M
Puts
$732K
Net Calls
+$1.56M
Net Calls Change
+$1.02M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.95M
2
Millennium Management
Millennium Management
New York
+$1.89M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.04M
4
OM
Opaleye Management
Massachusetts
+$787K
5
BlackRock
BlackRock
New York
+$716K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$5.83M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$2.1M
3
SFM
Sphera Funds Management
Israel
-$1.93M
4
Citigroup
Citigroup
New York
-$1.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
76
Cutler Group
California
$14K – – –
AF
77
Advisornet Financial
Minnesota
$12K – – –
TRCT
78
Tower Research Capital (TRC)
New York
$12K – – –
Victory Capital Management
79
Victory Capital Management
Texas
$8K – – –
TC
80
Truvestments Capital
Florida
$4K +$3.93K +22 New
CWA
81
Clarus Wealth Advisors
Arizona
$4K +$4.29K +24 New
UBS Group
82
UBS Group
Switzerland
$1K -$107K -596 -99%
PCM
83
Prelude Capital Management
New York
$1K -$179 -1 -17%
LTFS
84
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Northwestern Mutual Wealth Management
85
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Viking Global Investors
86
Viking Global Investors
Connecticut
– -$2.1M -11,741 Closed
SFM
87
Sphera Funds Management
Israel
– -$1.93M -10,801 Closed
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
– -$1.03M -5,756 Closed
Allianz Asset Management
89
Allianz Asset Management
Germany
– -$761K -4,265 Closed
CSS
90
Cubist Systematic Strategies
Connecticut
– -$345K -1,935 Closed
PP
91
Paloma Partners
Connecticut
– -$203K -1,140 Closed
QSS
92
Quantitative Systematic Strategies
Florida
– -$157K -878 Closed
Jane Street
93
Jane Street
New York
– -$96K -535 Closed
Squarepoint
94
Squarepoint
New York
– -$85K -475 Closed
MOACM
95
Mutual of America Capital Management
New York
– -$29K -160 Closed
QT
96
Quantamental Technologies
New York
– -$11K -64 Closed
PRC
97
Pearl River Capital
Michigan
– -$9K -48 Closed
KPW
98
Kore Private Wealth
New York
– -$7K -40 Closed
Macquarie Group
99
Macquarie Group
Australia
– -$4K -20 Closed
Bank of Montreal
100
Bank of Montreal
Ontario, Canada
– -$3.22K -18 Closed
1 2 3
4
5

ABEO Hedge Fund Activity: Q1 2019 in Review

87 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2019, worth a combined $230M — down 0.99% from $232M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ABEO and 4 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 23 added.

The largest buyer was Vanguard Group, adding an estimated $2.95M. The largest seller was Baker Bros. Advisors, cutting an estimated $5.83M.

  • 87 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2019, down from 99 in Q4 2018.
  • Funds reported $230M of Abeona Therapeutics stock for Q1 2019, down 0.99% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2019 and 16 closed out, a net change of -12 holders.
  • The largest Abeona Therapeutics buyer in Q1 2019 was Vanguard Group, an estimated $2.95M added.
  • The largest Abeona Therapeutics seller in Q1 2019 was Baker Bros. Advisors, an estimated $5.83M sold.

Based on aggregated 13F filings for Q1 2019.